Scholar Rock Holding Corporation Board of Directors

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Ms. Tracey M. Sacco M.B.A.

Ms. Tracey M. Sacco M.B.A.

Chief Commercial Officer

Ms. Caryn Parlavecchio

Ms. Caryn Parlavecchio

Chief Human Resources Officer

Mr. Ryan Iarrobino

Mr. Ryan Iarrobino

Senior Vice President of Clinical Development & Operations

Ms. Lisa Amaya Price

Ms. Lisa Amaya Price

Senior Vice President of Human Resources

Mr. Mo Qatanani Ph.D.

Mr. Mo Qatanani Ph.D.

Chief Scientific Officer

Ms. Junlin Ho J.D.

Ms. Junlin Ho J.D.

General Counsel & Corporate Secretary

Ms. Rushmie Nofsinger

Ms. Rushmie Nofsinger

Vice President of Corporate Affairs & Investor Relations

Ms. Erin Moore CPA

Ms. Erin Moore CPA

Senior Vice President of Finance

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.